Literature DB >> 9560255

Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens.

O Türeci1, U Sahin, C Zwick, M Koslowski, G Seitz, M Pfreundschuh.   

Abstract

Little is known about the function of human cancer/testis antigens (CTAs), such as MAGE, BAGE, GAGE, HOM-MEL-40, and NY-ESO-1, the expression of which is restricted to human malignancies and testis. When screening a cDNA expression library enriched for testis-specific representative long transcripts for reactivity with high-titered IgG antibodies from the serum of a patient with renal cell carcinoma, one repeatedly detected antigen, designated HOM-TES-14, turned out to be encoded by the synaptonemal complex protein 1 (SCP-1) gene. SCP-1 is known to be selectively expressed during the meiotic prophase of spermatocytes and is involved in the pairing of homologous chromosomes, an essential step for the generation of haploid cells in meiosis I. Investigation of a broad spectrum of normal and malignant tissues revealed expression of SCP-1 transcripts and antigen selectively in a variety of neoplastic tissues and tumor cell lines. Immunofluorescence microscopy analysis with specific antiserum showed a cell cycle phase-independent nuclear expression of SCP-1 protein in cancer cells. SCP-1 differs from other members of the class of CTA by its localization on chromosome 1 and its frequent expression in malignant gliomas, breast, renal cell, and ovarian cancer. The aberrant expression of SCP-1 in tumors might contribute to their genomic instability and suggests that the functional role of other CTA might also relate to meiosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9560255      PMCID: PMC20240          DOI: 10.1073/pnas.95.9.5211

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

Review 2.  The initiation of meiotic chromosome pairing: the cytological view.

Authors:  J Loidl
Journal:  Genome       Date:  1990-12       Impact factor: 2.166

Review 3.  Chromosome synapsis and genetic recombination: their roles in meiotic chromosome segregation.

Authors:  G S Roeder
Journal:  Trends Genet       Date:  1990-12       Impact factor: 11.639

4.  The synaptonemal complex in genetic segregation.

Authors:  D von Wettstein; S W Rasmussen; P B Holm
Journal:  Annu Rev Genet       Date:  1984       Impact factor: 16.830

5.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

6.  Gene conversion, recombination nodules, and the initiation of meiotic synapsis.

Authors:  A T Carpenter
Journal:  Bioessays       Date:  1987-05       Impact factor: 4.345

7.  Ott, a mouse X-linked multigene family expressed specifically during meiosis.

Authors:  S M Kerr; M H Taggart; M Lee; H J Cooke
Journal:  Hum Mol Genet       Date:  1996-08       Impact factor: 6.150

8.  Composition and role of the synaptonemal complex.

Authors:  M J Moses; M E Dresser; P A Poorman
Journal:  Symp Soc Exp Biol       Date:  1984

9.  Synaptonemal complex proteins.

Authors:  C Heyting; A J Dietrich; P B Moens; R J Dettmers; H H Offenberg; E J Redeker; A C Vink
Journal:  Genome       Date:  1989       Impact factor: 2.166

10.  Lambda ZAP: a bacteriophage lambda expression vector with in vivo excision properties.

Authors:  J M Short; J M Fernandez; J A Sorge; W D Huse
Journal:  Nucleic Acids Res       Date:  1988-08-11       Impact factor: 16.971

View more
  64 in total

Review 1.  Cancer/testis (CT) antigens, carcinogenesis and spermatogenesis.

Authors:  Yan-Ho Cheng; Elissa Wp Wong; C Yan Cheng
Journal:  Spermatogenesis       Date:  2011-07-01

Review 2.  Biology and regulation of ectoplasmic specialization, an atypical adherens junction type, in the testis.

Authors:  Elissa W P Wong; Dolores D Mruk; C Yan Cheng
Journal:  Biochim Biophys Acta       Date:  2007-11-19

3.  [Renal cell carcinoma associated proteins. Isolation, cloning and immunogenicity evaluation].

Authors:  A Haferkamp; M Hohenfellner; R Hautmann; M Zöller
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

4.  Screening for novel binding proteins interacting with human papillomavirus type 18 E6 oncogene in the Hela cDNA library by yeast two-hybrid system.

Authors:  Shuang Li; Ping Liu; Ling Xi; Xuefeng Jiang; Jianfeng Zhou; Shixuan Wang; Li Meng; Yunping Lu; Ding Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-02

5.  The journey from autologous typing to SEREX, NY-ESO-1, and cancer/testis antigens.

Authors:  Yao-Tseng Chen
Journal:  Cancer Immun       Date:  2012-05-01

Review 6.  Emerging Role and Future Directions of Immunotherapy in Advanced Ovarian Cancer.

Authors:  Thinle Chodon; Amit A Lugade; Sebastiano Battaglia; Kunle Odunsi
Journal:  Hematol Oncol Clin North Am       Date:  2018-10-01       Impact factor: 3.722

7.  Spontaneous high-titered IgG antibody responses against BCL-2 in patients with aggressive lymphomas.

Authors:  Carsten Zwick; Gerhard Held; Vera Hammermeister; Adnan Alahmad; Boris Kubuschok; Joerg Bittenbring; Manfred Ahlgrimm; Frank Neumann; Klaus-Dieter Preuss; Michael Pfreundschuh
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-21       Impact factor: 4.553

8.  Identification of specific autoantigens in Sjögren's syndrome by SEREX.

Authors:  Kazuo Uchida; Yoichi Akita; Keitaro Matsuo; Shigeyoshi Fujiwara; Atsuko Nakagawa; Yoshiaki Kazaoka; Hiroshi Hachiya; Yoshiyuki Naganawa; Ichiro Oh-Iwa; Kiyoshi Ohura; Shinsuke Saga; Tatsushi Kawai; Yoshinari Matsumoto; Kazuo Shimozato; Ken-Ichi Kozaki
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

9.  Cancer-testis specific gene OIP5: a downstream gene of E2F1 that promotes tumorigenesis and metastasis in glioblastoma by stabilizing E2F1 signaling.

Authors:  Jiang He; Yuzu Zhao; Erhu Zhao; Xianxing Wang; Zhen Dong; Yibiao Chen; Liqun Yang; Hongjuan Cui
Journal:  Neuro Oncol       Date:  2018-08-02       Impact factor: 12.300

10.  Expression of MAGE-C1/CT7 and selected cancer/testis antigens in ovarian borderline tumours and primary and recurrent ovarian carcinomas.

Authors:  Anne-Katrin Zimmermann; Jochen Imig; Agnes Klar; Christoph Renner; Dimitri Korol; Daniel Fink; Sylvia Stadlmann; Gad Singer; Alexander Knuth; Holger Moch; Rosmarie Caduff
Journal:  Virchows Arch       Date:  2013-03-26       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.